◀ Back to IL33
IL33 — ST2
Text-mined interactions from Literome
Palmer et al., Cytokine 2008
:
The IL-1 receptor accessory protein ( AcP ) is required for IL-33 signaling and soluble AcP enhances the ability of soluble
ST2 to
inhibit IL-33
Funakoshi-Tago et al., Cell Signal 2008
:
IL-33 rapidly
induced the formation of
ST2L complex containing IL-1 receptor associated kinase (IRAK), however, lack of TRAF6 abolished the recruitment of IRAK to ST2L
Cayrol et al., Proc Natl Acad Sci U S A 2009
:
We show that full-length
IL-33 ( 1-270 ) binds and
activates ST2 , similarly to IL-33 ( 112-270 ), and that cleavage by caspase-1 does not occur at the site initially proposed ( Ser ( 111 ) ), but rather after residue Asp ( 178 ) between the fourth and fifth predicted beta-strands of the IL-1-like domain
Mun et al., Cell Mol Life Sci 2010
(Bone Resorption) :
This action was suppressed by anti-ST2 antibody, suggesting that
IL-33 acts through its receptor
ST2 , but not by the receptor activator of NF-?B ligand ( RANKL ) decoy, osteoprotegerin, or anti-RANKL antibody
Fursov et al., Hybridoma (Larchmt) 2011
(Hypersensitivity...) :
ST2L activation by its ligand
IL-33 has been implicated in Th2 mediated immunity, inflammation, and allergic responses in vivo
Schmieder et al., Cytokine 2012
(Neoplasm Metastasis...) :
We also detected a counter-regulatory
effect of
IL-33 and IL-1 on the mRNA expression of soluble IL-33 receptor
ST2 and membrane bound receptor ST2L
Hong et al., Immunol Res 2013
:
IL-33 receptor complex is comprised of IL-1 receptor accessory protein ( IL-1RAcP ) and
ST2 that are
activated by
IL-33 ligand binding